The level of phosphorylated Akt predominantly reflects the expressive status of CerbB2 in invasive breast cancer.
Article 2013 en
Authors
YC
Yingkai Chi
JZ
Jing Zhao
CS
Cui Su-ping
Abstract
1 min read
Although some evidence has been documented on EGFR/PI3K mediation of Akt activation in breast cancers, ILK and DNA-PK have not been investigated so far. The aim of this study was to analyze the expression of phosphorylated Akt (pAkt) in breast cancer, with respect to its upstream regulators. The immunostaining of pAkt (Ser473) in 70 invasive breast cancers revealed that status of CerbB2 could play a major role in Akt phosphorylation, while ILK was also involved in the stimulated level of pAkt. The results would provide an important clue for the activation of Akt and potential targeted therapy in breast cancer.
Keefe T. Chan, Shaun Blake, Haoran Zhu, Jian Jian Kang, Anna Trigos, Piyush B. Madhamshettiwar, Jeannine Diesch, Lassi Paavolainen, Péter Horváth, Ross D. Hannan, Amee J. George, Elaine Sanij, Katherine M. Hannan, Kaylene J. Simpson, Richard B. Pearson
Haoran Zhu, Keefe T. Chan, Xinran Huang, Shaun Blake, Anna Trigos, Dovile Anderson, Darren J. Creek, David P. De Souza, Xi Wang, Caiyun Fu, Metta Jana, Elaine Sanij, Richard B. Pearson, Jian Jian Kang
Discussion(0)
No comments yet. Be the first to comment.